ANTICOAGULANT SODIUM CITRATE 4% W/V SOLUTION, USP
Google image searchProduct monograph
Active ingredient
sodium citrate dihydrate, 4 G/100 ML
DIN: 02377411
Dosage form(s): SOLUTION
Route(s) of administration: 0-UNASSIGNED
Description: FOR USE WITH APHERESIS DEVICES ONLY. NOT FOR DIRECT I.V. INFUSION.
Schedule: Ethical
Company: BAXTER CORPORATION
Date: 11-JUN-2024
ATC:
- V07 — ALL OTHER NON-THERAPEUTIC PRODUCTS (ATC, ATC/DDD, )
- V07A — ALL OTHER NON-THERAPEUTIC PRODUCTS (ATC, ATC/DDD)
- V07AC — Blood transfusion, auxiliary products (ATC, ATC/DDD)
Pharmaceutical standard: USP
